Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Tolerability of Arformoterol in Pediatric Asthma
NCT00583947Phase 2Completed
- Sponsor
- Sumitomo Pharma America
- Start
- Jan 2008
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of arformoterol in asthma (2 arms), sponsored by Sumitomo Pharma America. Primary endpoints: Mean Heart Rate, Change From Predose in Mean Heart Rate and 8 more. Started Jan 2008; status: completed.
02
Drugs
arformoterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00583947.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00583947.